STERIS Q4 2020 Earnings Report
Key Takeaways
STERIS plc reported a 7% increase in revenue for the fourth quarter of fiscal 2020, reaching $823.0 million. Net income increased to $123.3 million, or $1.44 per diluted share, compared to $108.7 million, or $1.27 per diluted share, in the same quarter of the previous year. The company experienced growth across all segments and a constant currency organic revenue growth of 8%. Due to the uncertainty of COVID-19, STERIS is not providing guidance for fiscal 2021 at this time.
Revenue increased by 7% to $823.0 million compared to Q4 2019.
Net income was $123.3 million, or $1.44 per diluted share, compared to $108.7 million, or $1.27 per diluted share, in Q4 2019.
Constant currency organic revenue growth was 8%.
The company is not providing guidance for fiscal 2021 due to COVID-19 uncertainty.
STERIS
STERIS
STERIS Revenue by Segment
Forward Guidance
Due to the uncertainty of COVID-19, STERIS is not providing guidance for fiscal 2021 at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income